"What we're trying to do is mimic the natural immune response of clearing infectious viruses and toxins before cells and organs can be infected."

— James Joyce, CEO/chairman of Aethlon Medical, discussing the initiation of a first-in-man study in India of the company's Hemopurifier device for the treatment of HIV/AIDS, "Aethlon to start first human study of Hemopurifier for HIV/AIDS," pp. 1, 6.